Loading...
XNAS
ROIV
Market cap15bUSD
Dec 12, Last price  
22.10USD
1D
3.56%
1Q
56.96%
IPO
112.50%
Name

Roivant Sciences Ltd

Chart & Performance

D1W1MN
XNAS:ROIV chart
P/E
—
P/S
529.05
EPS
—
Div Yield, %
—
Shrs. gr., 5y
27.49%
Rev. gr., 5y
-15.56%
Revenues
29m
-76.72%
2,324,00067,689,00023,795,00055,286,00061,280,000124,795,00029,053,000
Net income
-172m
L
-1,041,969,0001,200,509,000-900,233,000-924,116,000-1,230,024,0004,348,926,000-171,981,000
CFO
-839m
L+9.69%
-1,024,229,000-761,832,000-552,138,000-677,729,000-843,393,000-765,268,000-839,451,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Montes Archimedes Acquisition Corp. focuses to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. The company was founded in 2020 and is based in Menlo Park, California.
URL
http://roivant.com/
IPO date
Dec 03, 2020
Employees
904
Domiciled in
GB
Incorporated in
BM

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT